Advancements and Challenges in Immune Protection Strategies for Islet Transplantation
ABSTRACT Pancreatic islet transplantation is a crucial treatment for managing type 1 diabetes (T1D) in clinical settings. However, the limited availability of human cadaveric islet donors and the need for ongoing administration of immunosuppressive agents post‐transplantation hinder the widespread u...
Saved in:
Main Authors: | Xue Wang, Ziyuan Zeng, Dayan Li, Kai Wang, Wei Zhang, Yang Yu, Xi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Diabetes |
Subjects: | |
Online Access: | https://doi.org/10.1111/1753-0407.70048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An unmet need: Pancreatic beta cell replacement
by: F Mohamed, et al.
Published: (2024-04-01) -
Fibronectin in Immune Responses in Organ TransplantRecipients
by: Ana J. Coito, et al.
Published: (2000-01-01) -
Usp7 contributes to the tail regeneration of planarians via Islet/Wnt1 axis
by: Ang Liang, et al.
Published: (2025-01-01) -
FPR1 affects acute rejection in kidney transplantation by regulating iron metabolism in neutrophils
by: Peiyuan Li, et al.
Published: (2025-01-01) -
Sodium arsenite induces islets β-cells apoptosis and dysfunction via SET-Rac1-mediated cytoskeleton disturbance
by: Tianming Qiu, et al.
Published: (2025-01-01)